论文部分内容阅读
概述根据干细胞来源与患者的关系可将骨髓移植分为异基因、同基因和自体骨髓移植(ABMT),AB-MT主要限于肿瘤的治疗,而异基因、同基因骨髓移植既可治疗肿瘤又可治疗其它疾病,如遗传性疾病。1978年Blood杂志首次报道大剂量化疗加自体骨髓回输成功治疗儿童Burkitt,s淋巴瘤。该文的
Summary According to the relationship between stem cell sources and patients, bone marrow transplantation can be divided into allogeneic, isogenic and autologous bone marrow transplantation (ABMT), AB-MT is mainly limited to the treatment of tumors, while allogeneic, homologous bone marrow transplantation can treat both tumor and Treatment of other diseases, such as genetic diseases. Blood magazine first reported in 1978, high-dose chemotherapy plus autologous bone marrow transplantation for the successful treatment of children with Burkitt’s lymphoma. The text